QQQing Rui Qu

Qing Rui Qu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qing Rui Qu has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    10 °C Storage for the Preservation of Pig Kidney Grafts: A Porcine Autotransplant Model

    by Francisco Calderon Novoa, Kenji Nakamura, Kun Wang, Sujani Ganesh, Kaitlin Lees, Qing Rui Qu, Emma Mizdrak, Catherine Parmentier, Christian Hobeika, Samrat Ray, et al.

    Background.: Optimization of organ storage is essential to improve outcomes in kidney transplantation. Recent studies in lung transplantation highlight the impact of temperature on organ preservation, leading to a shift from traditional 4 °C “on-ice” storage toward 10 °C. We sought to determine whether these findings extend to kidney transplantation using 2 distinct porcine autotransplant models. Methods.: The initial donation after circulatory death model consisted of 30 min of warm ischemia followed by a brief 7.5 h storage on-ice (n = 5) or at 10 °C (n = 5). Grafts were retransplanted, the contralateral kidney was removed, and participants were followed up for 3 d. A second model simulating donation after brain death compared 24-h storage at 10 °C (n = 3) to a contemporaneous standard ice storage cohort (n = 3), followed by transplant, contralateral nephrectomy, and 7-d follow-up. Results.: The first model revealed discrete differences in creatinine, blood urea nitrogen, sodium, potassium, urine output, creatinine clearance, and fractional sodium excretion favoring 10 °C ( P > 0.05). Histology revealed reduced tubular injury ( P = 0.03) and interstitial inflammation ( P < 0.05) in the 10 °C group. Urinary neutrophil gelatin-associated lipocalin and thiobarbituric acid reactive substances were also reduced at 10 °C in the postoperative period ( P > 0.05). However, prolonged 24-h storage at 10 °C did not benefit kidney function, with significantly worse creatinine and blood urea nitrogen values over time ( P < 0.05). Conclusions.: The results of this initial study suggest that 10 °C storage may offer a modest protective effect in a short-storage porcine donation after circulatory death autotransplantation model; however, no benefit was demonstrated with prolonged storage, suggesting that any potential effects may be organ- and preservation solution-specific, as well as time-dependent. Larger studies are needed to draw more definitive conclusions.

  • Top Cited Papers
    Open Access

    Designing lipid nanoparticles using a transformer-based neural network

    by Alvin Chan, Ameya R. Kirtane, Qing Rui Qu, Xisha Huang, Jonathan Woo, Deepak A. Subramanian, Rajib Dey, Rika Semalty, Joshua D. Bernstock, Taksim Ahmed, et al.

    The RNA medicine revolution has been spurred by lipid nanoparticles (LNPs). The effectiveness of an LNP is determined by its lipid components and their ratios; however, experimental optimization is laborious and does not explore the full design space. Computational approaches such as deep learning can be greatly beneficial, but the composite nature of LNPs limits the effectiveness of existing single molecule-based algorithms to LNPs. Addressing this, our approach integrates the multi-component and multimodal features of composite formulations such as LNPs to predict their performance in an end-to-end manner. Here we generate one of the largest LNP datasets (LANCE) by varying LNP formulations to train our deep learning model, COMET. This transformer-based neural network not only accurately predicts the efficacy of LNPs but is adaptable to non-canonical LNP formulations such as those with two ionizable lipids and polymeric materials. Furthermore, COMET can predict LNP performance in a cell line outside of LANCE and predict LNP stability during lyophilization using only small training datasets. Experimental validation showed that our approach can identify LNPs that exhibit strong protein expression in vitro and in vivo, promising accelerated development of nucleic acid therapies with extensive potential across therapeutic and manufacturing applications.


  • Mitochondrial Transplantation Reduces Injury and Improves Liver Function in a Porcine Model of Hemi-hepatic Ischemia/Reperfusion

    by Christian Hobeika, Avinash Naraiah Mukkala, Kun Wang, Nicola Sariye Pollmann, Sujani Msc Ganesh, Francisco Calderon Novoa, Catherine Parmentier, Simon Msc Qu, Ramadan Karrout, Cindy Lin, et al.

    Objective: To assess mitochondrial transplantation (MitoTx) via portal vein infusion to reduce liver ischemia-reperfusion injury (I/R) in a survival porcine model. Summary Background Data: MitoTx has been shown to alleviate I/R injury in various organs. Methods: Male Yorkshire pigs (38±1 kg) were subjected to 2 hours of ischemia in the left hemi-liver (left portal-triad clamping), and at the beginning of reperfusion (marked as t=0 h), animals received a 1-hour infusion of autologous mitochondria (MT, 7×10^9/kg) or saline (controls) via the portal vein. Liver tissue oxygen saturation (sO2) was assessed by photoacoustic imaging. Results: Twelve pigs (6 MitoTx vs. 6 controls) underwent 2-hour left hemi-liver I/R. All pigs recovered and were ambulatory at t=6 hours. MitoTx reduced peak AST levels at t=2 hours compared with controls (299.83±46.62 vs. 878.83±255.09 UI/L; P=0.049). At t=24 hours, MitoTx pigs had lowered necrosis area percentage (8.01±4.12 vs. 23.40±7.33 %; P=0.08) in left livers—all right lobes had 0% necrotic area. MitoTx pigs had shorter prothrombin time, plateauing around t=8 hours (12.9±0.3 vs. 14.1±0.1 s; P=0.003), faster lactate clearance (P=0.003] and from the bile [HR: 1.4, (1.1, 1.7); P=0.009] compared with controls. At t=6 hours, MitoTx pigs had decreased IL-6 (304±71 vs. 686±87 pg/mL; P=0.007). Photoacoustic imaging showed that MitoTx pigs had a better recovery of sO2 from baseline in left livers compared with controls (at t=30 min; −3.05±2.72 vs. −15.19±2.92 %; P=0.016). Conclusion: MitoTx reduces injury and improves liver function after prolonged liver I/R, showing promise for liver transplantation.


  • Open Access

    Dolutegravir induces endoplasmic reticulum stress at the blood–brain barrier

    by Chang Huang, Qing Rui Qu, Md. Tozammel Hoque, Reina Bendayan

    Dolutegravir (DTG)‐based antiretroviral therapy is the contemporary first‐line therapy to treat HIV infection. Despite its efficacy, mounting evidence has suggested a higher risk of neuropsychiatric adverse effect (NPAE) associated with DTG use, with a limited understanding of the underlying mechanisms. Our laboratory has previously reported a toxic effect of DTG but not bictegravir (BTG) in disrupting the blood–brain barrier (BBB) integrity. The current study aimed to investigate the underlying mechanism of DTG toxicity. Primary cultures of mouse brain microvascular endothelial cells were treated with DTG and BTG at therapeutically relevant concentrations. RNA sequencing, qPCR, western blot analysis, and cell stress assays (Ca 2+ flux, H2DCFDA, TMRE, MTT) were applied to assess the results. The gene ontology (GO) analysis revealed an enriched transcriptome signature of endoplasmic reticulum (ER) stress following DTG treatment. We demonstrated that therapeutic concentrations of DTG but not BTG activated the ER stress sensor proteins (PERK, IRE1, p‐IRE1) and downstream ER stress markers (eIF2α, p‐eIF2α, Hspa5 , Atf4 , Ddit3 , Ppp1r15a , Xbp1 , spliced‐Xbp1 ). In addition, DTG treatment resulted in a transient Ca 2+ flux, an aberrant mitochondrial membrane potential, and a significant increase in reactive oxygen species in treated cells. Furthermore, we found that prior treatment with ER sensor or ER stress inhibitors significantly mitigated the DTG‐induced downregulation of tight junction proteins (Zo‐1, Ocln, Cldn5) and elevation of pro‐inflammatory cytokines and chemokines ( Il6 , Il23a , Il12b , Cxcl1 , Cxcl2 ). The current study provides valuable insights into DTG‐mediated cellular toxicity mechanisms, which may serve as a potential explanation for DTG‐associated NPAEs in the clinic.


  • Open Access

    Antiretroviral drug dolutegravir induces inflammation at the mouse brain barriers

    by Chang Huang, Md. Tozammel Hoque, Qing Rui Qu, Jeffrey Henderson, Reina Bendayan

    Integrase strand transfer inhibitors (INSTIs) based antiretroviral therapy (ART) is currently used as first‐line regimen to treat HIV infection. Despite its high efficacy and barrier to resistance, ART‐associated neuropsychiatric adverse effects remain a major concern. Recent studies have identified a potential interaction between the INSTI, dolutegravir (DTG), and folate transport pathways at the placental barrier. We hypothesized that such interactions could also occur at the two major blood–brain interfaces: blood‐cerebrospinal fluid barrier (BCSFB) and blood–brain barrier (BBB). To address this question, we evaluated the effect of two INSTIs, DTG and bictegravir (BTG), on folate transporters and receptor expression at the mouse BCSFB and the BBB in vitro, ex vivo and in vivo. We demonstrated that DTG but not BTG significantly downregulated the mRNA and/or protein expression of folate transporters (RFC/ SLC19A1 , PCFT/ SLC46A1 ) in human and mouse BBB models in vitro, and mouse brain capillaries ex vivo. Our in vivo study further revealed a significant downregulation in Slc19a1 and Slc46a1 mRNA expression at the BCSFB and the BBB following a 14‐day DTG oral treatment in C57BL/6 mice. However, despite the observed downregulatory effect of DTG in folate transporters/receptor at both brain barriers, a 14‐day oral treatment of DTG‐based ART did not significantly alter the brain folate level in animals. Interestingly, DTG treatment robustly elevated the mRNA and/or protein expression of pro‐inflammatory cytokines and chemokines ( Cxcl1, Cxcl2, Cxcl3, Il6, Il23, Il12 ) in primary cultures of mouse brain microvascular endothelial cells (BBB). DTG oral treatment also significantly upregulated proinflammatory cytokines and chemokine ( Il6, Il1β, Tnfα, Ccl2 ) at the BCSFB in mice. We additionally observed a downregulated mRNA expression of drug efflux transporters ( Abcc1, Abcc4 , and Abcb1a ) and tight junction protein ( Cldn3 ) at the CP isolated from mice treated with DTG. Despite the structural similarities, BTG only elicited minor effects on the markers of interest at both the BBB and BCSFB. In summary, our current data demonstrates that DTG but not BTG strongly induced inflammatory responses in a rodent BBB and BCSFB model. Together, these data provide valuable insights into the mechanism of DTG‐induced brain toxicity, which may contribute to the pathogenesis of DTG‐associated neuropsychiatric adverse effect.


  • Top Cited Papers
    Open Access

    Global, Regional, and National Economic Consequences of Stroke

    by Jakob V.E. Gerstl, Sarah E. Blitz, Qing Rui Qu, Alexander G. Yearley, Philipp Lassarén, Rebecca Lindberg, Saksham Gupta, Ari D. Kappel, Juan C. Vicenty-Padilla, Edoardo Gaude, et al.

    BACKGROUND: An understanding of global, regional, and national macroeconomic losses caused by stroke is important for allocation of clinical and research resources. The authors investigated the macroeconomic consequences of stroke disease burden in the year 2019 in 173 countries. METHODS: Disability-adjusted life year data for overall stroke and its subtypes (ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage) were collected from the GBD study (Global Burden of Disease) 2019 database. Gross domestic product (GDP, adjusted for purchasing power parity [PPP]) data were collected from the World Bank; GDP and disability-adjusted life year data were combined to estimate macroeconomic losses using a value of lost welfare (VLW) approach. All results are presented in 2017 international US dollars adjusted for PPP. RESULTS: Globally, in 2019, VLW due to stroke was $2059.67 billion or 1.66% of the global GDP. Global VLW/GDP for stroke subtypes was 0.78% (VLW=$964.51 billion) for ischemic stroke, 0.71% (VLW=$882.81 billion) for intracerebral hemorrhage, and 0.17% (VLW=$212.36 billion) for subarachnoid hemorrhage. The Central European, Eastern European, and Central Asian GBD super-region reported the highest VLW/GDP for stroke overall (3.01%), ischemic stroke (1.86%), and for subarachnoid hemorrhage (0.26%). The Southeast Asian, East Asian, and Oceanian GBD super-region reported the highest VLW/GDP for intracerebral hemorrhage (1.48%). CONCLUSIONS: The global macroeconomic consequences related to stroke are vast even when considering stroke subtypes. The present quantification may be leveraged to help justify increased spending of finite resources on stroke in an effort to improve outcomes for patients with stroke globally.